Clinical Trial

Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients

Study acronym: CAREBANK
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of CAREBANK study is to establish definitive relationships with human cardiac samples and clinical phenotypes in patients undergoing cardiac procedures. Specifically, the investigators aim at comparing atrial phenotypes from atrial fibrillation patients and controls. The work consists of three broad categories: A) role of atrial cardiomyopathy in atrial fibrillation; B) genetic defects predisposing to atrial fibrillation; and C) the role of inflammation in atrial fibrillation.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2018-02-21; most recent amendment 2024-05-07.
Status change: Recruiting → Active, Not Recruiting 2022-11-01
Trial Details
NCT Number NCT03444259
Lead Sponsor University of Turku
Collaborators: Brigham and Women's Hospital
Conditions Atrial Fibrillation, Coronary Artery Disease, Aortic Valve Stenosis, Aortic Valve Disease, Mitral Valve Disease, Cardiac Arrythmias, Cardiac Tumor, Cardiac Surgery
Enrollment 1,001 participants
Start Date 2016-02-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-08